Jefferies names Mindray stock a top pick with CNY 166 target
Published on 10/19/2026 at 09:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInvestor facts for October
- Jefferies named Mindray a top pick with a CNY 166.00 target on October 13, 2026.
- First-half revenue reached CNY 17.747 billion after rising 6.00 percent year over year.
- Mindray's market capitalization was CNY 203.0 billion as of October 19, 2026.
Mindray stock is preparing for its next earnings date after Futunn reported on October 13, 2026 that Jefferies had named the medical-device maker a top pick with a CNY 166.00 target. The latest Shenzhen quote was CNY 167.55 at 3:04 p.m. CST on October 19, 2026.
Revenue growth returns
The fundamental case rests on a stronger second quarter. Mindray generated CNY 9.395 billion of revenue in the second quarter of 2026, up 10.45 percent year over year, while net income attributable to shareholders reached CNY 2.467 billion, up 1.10 percent, according to Futunn.
For the first half of 2026, revenue rose 6.00 percent to CNY 17.747 billion, but net income attributable to shareholders fell 5.37 percent to CNY 4.797 billion. That split makes the October report important: sales momentum improved, while profit conversion remained weaker.
What do the targets imply?
The CNY 166.00 Jefferies target sits below the October 19 quote, so the note is better read as a valuation and recovery call than as a near-term upside signal. Futunn also identified centralized procurement, foreign-exchange swings and overseas competition as risks to margins.
Three dated signals
On September 30, 2026, Citic Securities said Mindray's first-half revenue reached CNY 17.747 billion and international revenue CNY 9.471 billion, up 13.67 percent year over year, according to Futunn. On October 13, 2026, the same research summary identified Jefferies' CNY 166.00 target. On October 30, 2026, Mindray is scheduled to report third-quarter results.
Next date for investors
The next scheduled company event is the third-quarter 2026 results announcement on October 30, 2026, a date reported by Simply Wall St.
Valuation meets execution
Mindray's market capitalization was CNY 203.0 billion on October 19, 2026, while its 52-week range was CNY 130.66 to CNY 227.81. The company therefore enters the results window with a meaningful gap between improving revenue growth and the pressure visible in first-half profit.
Mindray market facts
- Company: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- ISIN: CNE100003G67
- Ticker: 300760
- Primary exchange: Shenzhen Stock Exchange
- Latest quote: CNY 167.55 at 3:04 p.m. CST on October 19, 2026
- Market capitalization: CNY 203.0 billion (as of October 19, 2026)
- 52-week range: CNY 130.66-CNY 227.81 (as of October 19, 2026)
- Sector / Industry: Health Care / Medical Devices
- Next earnings date: October 30, 2026
Market context: Market report Shanghai Composite.
